Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
A budget review helps you spot gaps and realign spending with goals. This introduction highlights essential items to include for a clear, actionable assessment.
17,603 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Australian regulators have activated full Travel Rule checks for crypto transfers. Exchanges and other service provid...
A late-June ethics filing shows Trump’s government filing just disclosing roughly $1.4 billion in crypto earnings for...
Brookfield Asset Management is expanding its AI infrastructure pact with Bloom Energy to $25 billion, signaling a maj...
Palantir stock is shaping up for a year-end move as AI demand and expanding government and commercial contracts fuel ...
First MLS appoints Jenni Bonura as Chief Growth Officer, signaling a bold expansion push across Georgia and the South...
Michael Burry has added a Micron short, expanding a wager that AI-driven chip stocks may soon pull back. The move com...
Nike’s quarterly results hide a fragile rebound, with internal missteps and regional weakness clouding CEO Elliott Hi...
JPMorgan warns that Michael Saylor’s aggressive BTC purchases, financed through complex instruments, could become a f...
Bitcoin, Ethereum, and other top tokens jumped over the holiday weekend as ETF flows turned bullish and traders retur...
Joby Aviation stock surging has a few clear triggers: progress on electric air mobility, a strategic partnership with...
Bitcoin climbs toward $63,000 as leverage re-enters crypto markets, triggering quick swings and prompting traders to ...